Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

The Role of Hippocampal Interneuron Migration in Neurodevelopmental Disorders: A Systematic Review.
(2026 Sep)
Hippocampus 36(5): e70121
Till MAC, Reid HMO, Murphy I, Christie BR

Cardiometabolic factors and risk of dementia in people with type 2 diabetes in England: a large retrospective cohort study.
(2026 Aug 17)
BMJ Open Diabetes Res Care 14(4):
Lai HT, Chang K, Sharabiani MT, Valabhji J, Gregg EW, Middleton LT, Majeed A, Pearson-Stuttard J, Millett CJ, Bottle A, Vamos EP

Global prevalence and influencing factors, protective factors, and outcomes of anxiety, depression, and post-traumatic stress disorder among refugee children and adolescents: a systematic review and meta-analysis.
(2026 Aug)
Arch Psychiatr Nurs 63(): 152166
Salari N, Alilou S, Hashemian SH, Jalili P, Khani M, Lotfi F, Mohammadi M

Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
(2026 Aug 17)
Ann Oncol
Zhang AY, Thomas H, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Herberstein C, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McLaughlin RA, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Vera-Badillo F, Williams SG, Zielinski RR, Stockler MR, Davis ID, Sweeney CJ

Lara Cassidy.
(2026 Aug 17)
Curr Biol 36(16): R884-R886
Cassidy L

Show complete publication list

In the News